Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,246 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07097896Recruiting
Lung valve treatment for emphysema
This trial tests a small silicone valve placed in your airways to help you breathe better if you have emphysema. It may be an option if you have severe breathing problems and are not getting enough relief from medicine alone.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07095907Recruiting
Eye surgery for scar tissue on the retina
This study is for people who have a stage III or IV epiretinal membrane, a thin layer of scar tissue on the retina that can cause blurry or distorted central vision. It tests a surgical approach called controlled macular detachment to see how it helps visual symptoms and recovery.
Mexico CityAges 18 years+ - NCT07096336Recruiting
Vitamin D3 and brain waves in Parkinson's study
This study tests whether taking vitamin D3 can improve brain wave patterns in men with Parkinson's disease who have low vitamin D levels. It may help understand if vitamin D supports brain health.
Dhaka, ShahbagAges 51–70 - NCT07098390Recruiting
Relaxation to Reduce Fear and Pain After Joint Replacement
This study tests whether a simple relaxation technique (progressive muscle relaxation) can help reduce fear of falling, pain, and anxiety after hip or knee replacement surgery. It may be a safe, drug-free way to feel better during recovery.
AnkaraAges 18 years+ - NCT07105189Recruiting
Study of wireless vital sign monitors after spinal surgery
This trial tests whether a wireless, wearable monitor can safely track your heart rate and other vital signs after complex spinal surgery, reducing the need for frequent nurse checks. If you are having extensive back surgery and stay in the hospital for at least 3 days, you may be eligible.
CopenhagenAges 18 years+ - NCT07104942Recruiting
Breathing muscle strength in bronchiectasis
This trial tests whether a breathing muscle exercise can help people with bronchiectasis breathe easier. It looks at how the exercise affects your ability to cough and clear mucus.
IstanbulAges 18–65 - NCT07104214Recruiting
Predicting stomach retention risk before sedated endoscopy
This study is building a tool to predict if a patient's stomach will empty normally before a sedated upper endoscopy (gastroscopy). It tests risk factors that help doctors plan safer procedures.
Hangzhou, ZhejiangAges 18 years+ - NCT07102264Recruiting
Ultrasound test for thyroid stiffness before surgery
This study tests a new, non-invasive ultrasound method to measure how compressible (squishy) your thyroid gland is, before you have surgery to remove it. The goal is to see if this safe, painless measurement can help surgeons plan better.
BernAges 18 years+ - NCT07102667Enrolling by invitation
Protein intake for muscle health in older kidney patients
This study tests how much protein older adults with kidney disease and muscle loss should eat to build or maintain muscle. You will follow a protein plan and do simple resistance exercises to see if it helps your strength.
BangkokAges 65 years+ - NCT07096895Recruiting
Special Endoscopic Procedure for Blocked Bile Duct Access
This trial tests a special endoscopic procedure (EDEE) to reach the bile duct when the usual pathway is blocked, which can happen with certain benign or malignant conditions. If standard methods can't access the area, this approach may offer an alternative.
DüsseldorfAges 18 years+ - NCT07105033Recruiting
Focused ACT for advanced cancer patients
This study tests a counseling program called Focused ACT (FACT) to help patients with advanced cancer cope with stress and death anxiety. It involves talking with a counselor about important areas of your life.
Houston, TexasAges 18 years+ - NCT07100288Recruiting
Study of the ovary ligament in ovarian cancer patients
This trial looks at a specific ligament near the ovary in patients with epithelial ovarian cancer to better understand the disease. It is for people who had surgery with no cancer left behind.
Las Palmas de Gran CanariaAges 18 years+ - NCT07096414Recruiting
Vitamin D3 and brain waves in men with epilepsy and low vitamin D
This trial tests whether taking vitamin D3 supplements changes brain wave activity in men with epilepsy who also have low vitamin D levels. It aims to see if vitamin D could help improve brain function.
Dhaka, Shahbag, DhakaAges 20–40 - NCT07097935RecruitingPhase 1/Phase 2
Study of HS-10516 combo therapy for advanced kidney cancer
This trial tests a new combination therapy for people with advanced clear cell kidney cancer that has progressed after at least one prior treatment. It aims to see if adding HS-10516 to standard care can help shrink tumors or slow the disease.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07101601RecruitingPhase 1
Testing DM5167 for advanced solid tumors with BRCA mutations
This trial is testing a new drug called DM5167 for people whose advanced solid tumors have a BRCA1 or BRCA2 gene mutation. The goal is to see if the drug can shrink tumors or slow their growth.
Gyeonggi-doAges 19 years+ - NCT07103018RecruitingPhase 1
Study of KTX-2001 for men with advanced prostate cancer
This trial tests a new drug called KTX-2001, possibly combined with another drug (darolutamide), for men whose prostate cancer has spread and stopped responding to standard hormone treatments. The goal is to see if it can help shrink tumors or slow the cancer's growth.
San Francisco, CaliforniaAges 18 years+ - NCT07102004RecruitingPhase 1/Phase 2
Testing a new drug for advanced solid tumors
This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.
BeijingAges 18 years+ - NCT07100730RecruitingPhase 3
A new drug for recurrent glioblastoma vs standard care
This trial tests a new targeted drug, TLX101-Tx, added to standard care for people with glioblastoma that has come back after initial treatment. It aims to see if the combination helps control the tumor better than standard care alone.
Gold Coast, QueenslandAges 18 years+ - NCT07096882RecruitingPhase 1
SDTM001 injection after lung cancer surgery
This trial tests an injection called SDTM001 as an extra treatment after surgery for people with non-small cell lung cancer (NSCLC). It aims to see if it can help prevent the cancer from coming back.
Chengdu, SichuanAges 18–70 - NCT07096258Recruiting
Blood test to guide first treatment for advanced lung cancer
This trial is for people with advanced non-small cell lung cancer (NSCLC) who have not yet started treatment. It studies a simple blood test that checks for genetic changes in the cancer, to help doctors choose the most effective first treatment.
Nancy, LorraineAges 18 years+ - NCT07103668RecruitingPhase 3
Study of a new drug for advanced stomach cancer after prior treatments
This trial tests an experimental therapy for people with advanced stomach or gastroesophageal junction cancer that has not responded to at least two prior treatments. The therapy targets a specific protein (CLDN18.2) found on cancer cells. The goal is to see if this approach can help control the disease.
BeijingAges 18 years+ - NCT07096869RecruitingPhase 1
Breast cancer trial comparing two forms of paclitaxel
This study checks if a generic version of paclitaxel protein-bound particles works the same as the brand-name drug in people with breast cancer. It's for patients whose cancer has spread or returned, and who might benefit from this medicine alone.
Changchun, JilinAges 18–75 - NCT07098052RecruitingPhase 1
Study of HDM2020 for advanced solid tumors
This trial is testing a new drug called HDM2020 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and how well it works.
Guangzhou, GuangdongAges 18–75 - NCT07102342RecruitingPhase 1/Phase 2
Cell therapy for Parkinson's disease
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
New York, New YorkAges 30–75
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,246 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.